C4 Therapeutics (CCCC) Stock: Buy, Sell, or Hold?
CCCC - C4 Therapeutics, Inc.
$2.75
-0.03 (-1.08%)
▼
5d:
-12.97%
30d:
-19.47%
90d:
-23.18%
HOLD
LOW Confidence
Analysis Updated: Oct 16, 2026 12:00 AM ET
Earnings: Nov 05, 2026
19d
Get Alerted When CCCC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CCCC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CCCC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CCCC is currently trading at $2.75, which is considered oversold relative to its 30-day fair value range of $2.90 to $3.41.
Technical Outlook: Technically, CCCC is in a strong uptrend. Immediate support is located at $2.59, while resistance sits at $3.33.
Market Sentiment: CCCC scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $12.86 (+362.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CCCC is in a strong uptrend. Immediate support is located at $2.59, while resistance sits at $3.33.
Market Sentiment: CCCC scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $12.86 (+362.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.90 -
$3.41
Company Quality Score
71/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 362.5% below Wall St target ($12.86)
- CAUTION: Bottoming setup, but lagging the sector by 15% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-13.0%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$2.90 -
$3.41
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.59
Resistance Level
$3.33
Current Trend
Strong Uptrend
Technical data as of
Oct 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.89
Wall Street Target
$12.86
(+362.5%)
Revenue Growth (YoY)
2.8%
Profit Margin
-289.4%
Share & Embed Analysis
Last updated: October 16, 2026 12:28 PM ET
Data refreshes hourly during market hours. Next update: 1:28 PM
Data refreshes hourly during market hours. Next update: 1:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CCCC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
27 analysts |
$92 | 70 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$109 | 74 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$285 | 51 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
17 analysts |
$37 | 71 BUY |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$129 | 71 BUY |
